GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $450,122 (100.0% shares, 0.0% debt)

Holdings (36)

ARENA PHARMACEUTICALS INC 11.0%
Value ($000) $49,320 Shares 530,670 Est. Cost $60.39 Unrealized
EXEL EXELIXIS INC 7.1%
Value ($000) $31,990 Shares 1,750,000 Est. Cost $21.47 Unrealized -10.9%
XENE XENON PHARMACEUTICALS INC 6.6%
Value ($000) $29,678 Shares 950,000 Est. Cost $20.67 Unrealized +44.6%
TVTX TRAVERE THERAPEUTICS INC 5.5%
Value ($000) $24,832 Shares 800,000 Est. Cost $24.95 Unrealized +12.9%
ANAB ANAPTYSBIO INC 4.6%
Value ($000) $20,581 Shares 592,250 Est. Cost $24.89 Unrealized +27.4%
VRTX VERTEX PHARMACEUTICALS INC 4.1%
Value ($000) $18,666 Shares 85,000 Est. Cost $195.24 Unrealized -0.4%
BCAB BIOATLA INC 3.8%
Value ($000) $16,966 Shares 864,300 Est. Cost $38.65 Unrealized -33.8%
GLPG GALAPAGOS NV 3.7%
Value ($000) $16,539 Shares 300,000 Est. Cost $55.13 Unrealized
RLMD RELMADA THERAPEUTICS INC 3.6%
Value ($000) $16,161 Shares 717,320 Est. Cost $22.24 Unrealized 0.0%
MGNX MACROGENICS INC 3.6%
Value ($000) $16,050 Shares 1,000,000 Est. Cost $18.17 Unrealized +3.6%
CYTK CYTOKINETICS INC 3.5%
Value ($000) $15,953 Shares 350,000 Est. Cost $29.44 Unrealized +31.1%
TRICIDA INC 3.0%
Value ($000) $13,384 Shares 1,400,000 Est. Cost $4.49 Unrealized
RIGEL PHARMACEUTICALS INC 2.9%
Value ($000) $13,250 Shares 5,000,000 Est. Cost $3.25 Unrealized
SRPT SAREPTA THERAPEUTICS INC 2.9%
Value ($000) $13,094 Shares 145,405 Est. Cost $85.49 Unrealized 0.0%
BCYC BICYCLE THERAPEUTICS PLC 2.7%
Value ($000) $12,174 Shares 200,000 Est. Cost $60.87 Unrealized
PCVX VAXCYTE INC 2.6%
Value ($000) $11,895 Shares 500,000 Est. Cost $23.45 Unrealized -0.8%
RNAM AVIDITY BIOSCIENCES INC 2.6%
Value ($000) $11,885 Shares 500,000 Est. Cost $23.88 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 2.6%
Value ($000) $11,632 Shares 800,000 Est. Cost $15.70 Unrealized -3.5%
RCKT ROCKET PHARMACEUTICALS INC 2.4%
Value ($000) $10,926 Shares 500,526 Est. Cost $38.30 Unrealized -28.8%
SLN SILENCE THERAPEUTICS PLC 2.4%
Value ($000) $10,618 Shares 444,443 Est. Cost $23.89 Unrealized
DYN DYNE THERAPEUTICS INC 2.2%
Value ($000) $10,047 Shares 845,000 Est. Cost $18.15 Unrealized -22.6%
PASSAGE BIO INC 2.1%
Value ($000) $9,640 Shares 1,518,095 Est. Cost $6.35 Unrealized
PRQR PROQR THRAPEUTICS N V 2.0%
Value ($000) $8,980 Shares 1,121,122 Est. Cost $7.59 Unrealized +0.4%
URGN UROGEN PHARMA LTD 1.8%
Value ($000) $8,306 Shares 873,424 Est. Cost $15.60 Unrealized -9.6%
CHINOOK THERAPEUTICS INC 1.4%
Value ($000) $6,362 Shares 390,041 Est. Cost $16.31 Unrealized
KINIKSA PHARMACEUTICALS LTD 1.4%
Value ($000) $6,317 Shares 536,738 Est. Cost $11.43 Unrealized
PIERIS PHARMACEUTICALS INC 1.3%
Value ($000) $5,859 Shares 1,550,000 Est. Cost $3.78 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.2%
Value ($000) $5,450 Shares 411,937 Est. Cost $15.92 Unrealized 0.0%
MAGENTA THERAPEUTICS INC 1.2%
Value ($000) $5,183 Shares 1,170,000 Est. Cost $9.65 Unrealized
PYXS PYXIS ONCOLOGY INC 1.0%
Value ($000) $4,388 Shares 400,000 Est. Cost $11.45 Unrealized 0.0%
AEGLEA BIOTHERAPEUTICS INC 1.0%
Value ($000) $4,324 Shares 910,251 Est. Cost $7.47 Unrealized
NEKTAR THERAPEUTICS 0.6%
Value ($000) $2,755 Shares 203,900 Est. Cost $17.96 Unrealized
ABUS ARBUTUS BIOPHARMA CORP 0.6%
Value ($000) $2,602 Shares 668,907 Est. Cost $3.88 Unrealized 0.0%
CABA CABALETTA BIO INC 0.4%
Value ($000) $1,791 Shares 472,433 Est. Cost $10.67 Unrealized 0.0%
RFL RAFAEL HLDGS INC 0.3%
Value ($000) $1,457 Shares 285,714 Est. Cost $45.91 Unrealized -70.7%
POINT BIOPHARMA GLOBAL INC 0.2%
Value ($000) $1,067 Shares 190,520 Est. Cost $5.60 Unrealized